Germany Blood-based Biomaker For Sports Medicine Market Size & Outlook
Germany blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Germany blood-based biomaker for sports medicine market highlights
- The Germany blood-based biomaker for sports medicine market generated a revenue of USD 44.8 million in 2023 and is expected to reach USD 86.6 million by 2030.
- The Germany market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 44.8 million |
| Market revenue in 2030 | USD 86.6 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Germany accounted for 6.7% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.08% in 2023. Horizon Databook has segmented the Germany blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The rising number of sports-related injuries in Germany is expected to drive significant growth in the blood-based biomarkers for sports medicine market. According to an MDPI report published in December 2023, an average of four people in Germany suffer sports-related injuries every minute, leading to around 2,000,000 injuries annually.
The majority of these injured athletes (79.63%) are struggling with chronic injuries, with 72.22% of cases falling into this category. Medical treatment is widely sought, with 90.74% of these athletes receiving some form of medical care. However, a notable portion of athletes (11.29%) seek little to no treatment, and only 8.06% take advantage of rehabilitation services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Germany Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
